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■ Original Article ■
Introduction
Predicting the prognosis of patients in intensive care unit (ICU) is important for evaluating the quality of ICU, and 
making decisions regarding further management [1]. The accurate methods of predicting outcomes of patients have been 
needed, therefore many scoring systems for predicting prognosis including mortality of patients have been proposed. 
However, predicting the prognosis of critically ill patients whose condition fluctuates every other moments is challeng-
ing. Recently developed assessments based on physiologic variables have limitations due to requiring many variables 
which are not collected for all patients admitted to ICU [1]. Therefore, it is necessary to identify noninvasive, easy 
means to predict the prognosis of the patients in ICU, especially for pediatric patients.
Korean J Crit Care Med
2017 November 32(4):347-355 / https://doi.org/10.4266/kjccm.2017.00437
ISSN 2383-4870 (Print)ㆍISSN 2383-4889 (Online)
2014. 11  V
ol. 29  N
o. 04 (243-348)
2014. 11  Vol. 29  No. 04
Editorial
Do We Successfully Achieve Therapeutic Hypothermia? (243)
Review
How to Enhance Critical Care in Korea: Challenges and Vision (246)
Original Articles
Implementing a Sepsis Resuscitation Bundle Improved Clinical Outcome: A Before-and-After Study (250)
Extended-Spectrum β-Lactamase and Multidrug Resistance in Urinary Sepsis Patients Admitted to the Intensive Care Unit (257)
Clinical Characteristics of Respiratory Extracorporeal Life Support in Elderly Patients with  (266) 
Severe Acute Respiratory Distress Syndrome 
Predicting Delayed Ventilator Weaning after Lung Transplantation: The Role of Body Mass Index (273)
Comparison of Morphine and Remifentanil on the Duration of Weaning from Mechanical Ventilation (281)
Acute Physiologic and Chronic Health Examination II and Sequential Organ Failure Assessment Scores for Predicting  (288) 
Outcomes of Out-of-Hospital Cardiac Arrest Patients Treated with Therapeutic Hypothermia 
Effectiveness of Bradycardia as a Single Parameter in the Pediatric Acute Response System (297)
Prognostic Value and Optimal Sampling Time of S-100B Protein for Outcome Prediction in (304) 
Cardiac Arrest Patients Treated with Therapeutic Hypothermia 
Change in Red Cell Distribution Width as Predictor of Death and Neurologic Outcome in (313) 
Patients Treated with Therapeutic Hypothermia after Out-of-Hospital Cardiac Arrest 
Traumatic Liver Injury: Factors Associated with Mortality (320)
Case Reports
Green Urine after Propofol Infusion in the Intensive Care Unit (328)
Cardiac Arrest due to Recurrent Ventricular Fibrillation Triggered by Unifocal Ventricular (331) 
Premature Complexes in a Silent Myocardial Infarction 
Kawasaki Disease with Acute Respiratory Distress Syndrome after Intravenous Immunoglobulin Infusion (336)
Methemoglobinemia Caused by an Inert Ingredient after Intentional Ingestion of Pesticide (341)
Lobar Bronchial Rupture with Persistent Atelectasis after Blunt Trauma (344)
Erratum
Patients with Acute Respiratory Distress Syndrome Caused by Scrub Typhus: Clinical (348) 
Experiences of Eleven Patients 
ISSN 2383-4870 (Print)    ISSN 2383-4889 (Online)
Received on August 2, 2016     Revised on October 17, 2016     Accepted on November 25, 2016
Correspondence to: Yoon Hee Kim, Department of Pediatrics, Gangnam Severance Hospital, Yonsei University College of Medicine, 211 Eonju-ro, Gangnam-gu, Seoul 06273, Korea 
Tel: +82-2-2019-3356, Fax: +82-2-2019-4881, E-mail: yhkim@yuhs.ac
*No potential conflict of interest relevant to this article was reported.
cc  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ 
licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright ⓒ 2017 The Korean Society of Critical Care Medicine
Serum Albumin as a Biomarker of Poor Prognosis  
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Background: Serum albumin as an indicator of the disease severity and mortality is suggested in adult patients, but its role in pediat-
ric patients has not been established. The objectives of this study are to investigate the albumin level as a biomarker of poor progno-
sis and to compare it with other mortality predictive indices in children in intensive care unit (ICU).
Methods: Medical records of 431 children admitted to the ICU at Severance Hospital from January 1, 2012 to December 31, 2015 were 
retrospectively analyzed. Children who expired within 24 hours after ICU admission, children with hepatic or renal failure, and those 
who received albumin replacement before ICU admission were excluded.
Results: The children with hypoalbuminemia had higher 28-day mortality rate (24.60% vs. 9.28%, P < 0.001), Pediatric Index of Mortal-
ity (PIM) 3 score (9.23 vs. 8.36, P < 0.001), Pediatric Risk of Mortality (PRISM) III score (7.0 vs. 5.0, P < 0.001), incidence of septic shock (12% 
vs. 3%, P < 0.001), C-reactive protein (33.0 mg/L vs. 5.8 mg/L, P < 0.001), delta neutrophil index (2.0% vs. 0.6%, P < 0.001), lactate level 
(1.6 mmol/L vs. 1.2 mmol/L, P < 0.001) and lower platelet level (206,000/μl vs. 341,000/μl, P < 0.001) compared to the children with 
normal albumin level. PIM 3 (r = 0.219, P < 0.001) and PRISM III (r = 0.375, P < 0.001) were negatively correlated with serum albumin 
level, respectively. 
Conclusions: Our results highlight that hypoalbuminemia can be a biomarker of poor prognosis including mortality in the children in 
ICU. 
Key Words: albumins; intensive care units; mortality; pediatrics.  
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The critical condition of patients admitted to the ICU is 
vulnerable to oxidative stresses caused by reactive oxy-
gen species which result in injuries to cells and tissues 
and activating extracellular antioxidant defense network 
consecutively [2,3]. There are many antioxidants in ex-
tracellular fluids including albumin, which is known as 
one of the most potent antioxidants [4,5]. 
Therefore, serum albumin as an indicator of the dis-
ease severity and the mortality is suggested and studied 
in adult patients [6,7] and it has been found that the de-
crease in serum albumin concentration significantly rais-
es the mortality [8]. Hypoalbuminemia (serum albumin 
<3.5 g/dl) is frequently observed in patients admitted to 
the pediatric intensive care unit (PICU) [2], but its role in 
pediatric patients has not been established.
In this study, we evaluated the value of serum albumin 
level at PICU admission as a biomarker of poor progno-
sis including mortality in critically ill children regardless 
of underlying etiology and compared serum albumin 
level with other mortality predictive indices which are 
universally used in many PICU settings.
Materials and Methods 
1) Study population  
We enrolled 431 pediatric patients admitted to the ICU 
in Severance Hospital with the exception of cardiology 
and surgical unit where patients who need cardiologic 
surgeries admit separately between January 1, 2012 and 
December 31, 2015. Patients were over 1 month and 
under 18 years of age. Patients who expired within 24 
hours after ICU admission, had hepatic or renal failure, 
or received albumin replacement before ICU admission 
were excluded. We defined infection by the presence of a 
pathogen-proven infection (posi tive culture, tissue stain, 
or polymerase chain reaction test) or a clinical syndrome 
associated with a high probability of infection, such as 
positive findings on clinical examination, imaging, or 
laboratory tests (e.g., white blood cells in a normally 
ster ile body fluid, perforated viscus, chest radiograph 
consistent with pneumonia, petechial or purpuric rash, 
or purpura fulmi nans) [9]. This study was approved by 
the Institutional Review Board of Severance Hospital 
(protocol No. 4-2013-0207). The informed consent was 
waived.
2) Data collection
All data were collected and analyzed retrospectively. 
Initial blood sample results which obtained at the time 
of ICU admission were analyzed. Hypoalbuminemia 
was defined by serum albumin concentration <3.5 g/dl. 
Age, sex, nutritional status, mortality, length of ICU stay, 
reason for admission, sepsis, septic shock, requirement 
for respiration support in the first 1 hour of ICU, and re-
quirement for mechanical ventilation within 24 hours of 
ICU admission were collected.
3) Statistical analysis 
Baseline characteristics of patients were compared us-
ing independent two sample t-test and Mann-Whitney U-
test, as appropriate. Groups were compared by the chi-
square test for categorical variables. 
Univariable and multivariable logistic regression model 
were used to identify independent predictors of mortal-
ity and to examine the relation between serum albumin 
and mortality. The correlation between serum albumin 
and other mortality predictive indices was assessed using 
Spearman’s method. Survival curves were determined 
using Kaplan-Meier method. Statistical analyses were 
performed with IBM SPSS version 23.0 (IBM Corp., Ar-
monk, NY, USA).
The predictive values of serum albumin, Pediatric Index 
of Mortality (PIM) 3 score, and Pediatric Risk of Mortality 
(PRISM) III score were compared by calculating the area 
under the receiver operating characteristic curve (AUC). 
Receiver operating characteristic curve for discrimination 
and comparisons of AUCs between other mortality predic-
tive indices and albumin incorporated models (PIM 3 with 
albumin, and PRISM III with albumin) were used by SAS 
version 9.3 (SAS Institute, Cary, NC, USA).
Net reclassification improvement (NRI) and integrated 
https://doi.org/10.4266/kjccm.2017.00437
Young Suh Kim, et al. Albumin as a Biomarker of Poor Prognosis  349
discrimination improvement (IDI) were performed to as-
sess improvement in mortality prediction after incorpo-
rating albumin to PIM 3, PRISM III by using R software 
version 3.0.1 (R Foundation for Statistical Computing, 




A total of 431 pediatric patients had diverse underlying 
diseases and reasons for ICU admission (Table 1). The 
most common underlying disease was neurologic disease 
(248 patients, 58%), and others were hemato-oncologic 
disease (78 patients, 18%), pulmonary disease (23 pa-
tients, 5%), gastro-intestinal disease (15 patients, 3%), 
cardiologic disease (11 patients, 3%), endocrinologic 
disease (six patients, 1%), nephrologic disease (six pa-
tients, 1%), and so on. The most common reason for ICU 
admission is airway-lung problem (268 patients, 62%) 
and other reasons were neurologic problem (64 patients, 
15%), postoperation or procedure care (37 patients, 9%), 
hemato-oncologic problem (15 patients, 3%), nephro-
logic problem (14 patients, 3%), gastrointestinal problem 
(nine patients, 2%), metabolic diseases (three patients, 
1%) and others (21 patients, 5%) sequentially. The pa-
Table 2. Subjects’ characteristics 
Variable Value (n = 431)
Age (yr)   3.1 (1.1–7.9)
Male sex 261 (60.56)
Nutritional state
Well nourished 275 (63.81)
Malnourished (weight for age <3%) 149 (34.57)
Obese (weight for age ≥97%)  7 (1.62)
Requirement for respiration support within 1 
hour ICU admission
384 (89.10)
Requirement for mechanical ventilation within 
24 hours ICU admission
334 (77.49)
Laboratory variable
White blood cell (/µL) 10,930 (6,240–17,480)
Absolute neutrophil count (/µL)  7,680 (3,830–13,253)
Delta neutrophil index (%)    1.5 (0.0–5.2)
Hemoglobin (g/dl)    10.7 (9.2–11.9)
Platelets (103/µl)    271 (151–398)
Erythrocyte sedimentation rate (mm/h)   21.0 (6.0–57.0)
C-reactive protein (mg/L)   13.6 (2.6–57.9)
Lactate (mmol/L)   1.6 (0.9–3.1)
Serum albumin (g/dl)   3.4 (2.9–3.7)
Hypoalbuminemia (<3.5 g/dl) 237 (54.99)
Length of ICU stay (d)    9.0 (4.0–18.0)
ICU scoring system
PIM 3     8.46 (4.30–22.63)
PRISM III    5.5 (2.0–12.0)
Mortality  84 (19.49)
28-Day mortality  76 (17.63)
Sepsis  82 (19.02)
Septic shock 33 (7.65)
Values are presented as median (interquartile range) or number (%). 
ICU: intensive care unit; PIM: Pediatric Index of Mortality; PRISM: Pediatric Risk 
of Mortality.
Table 1. Underlying disease and main reason for ICU admission 
of pediatric patients
Variable No. (%) (n = 431)
Underlying disease
Neurologic disease 248 (57.54)
Hemato-oncologic disease  78 (18.10)
Pulmonary disease 23 (5.34)
Gastro-intestinal disease 15 (3.48)
Cardiologic disease 11 (2.55)
Endocrinologic disease  6 (1.39)
Nephrologic disease  6 (1.39)
Metabolic disease  1 (0.23)
No underlying disease  43 (10.00)
Main reason for ICU admission
Airway-lung problem 268 (62.18)
Neurologic problem  64 (14.85)
Postoperation and procedure care 37 (8.58)
Hemato-oncologic emergency 15 (3.48)
Nephrologic problem 14 (3.25)
Gastrointestinal problem  9 (2.09)
Metabolic disease  3 (0.70)
Othersa 21 (4.87)
ICU: intensive care unit.
aEndocrinologic emergency, close monitoring, cardiovascular disease.
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tients’ baseline characteristics are presented in Table 2. 
The median age of patients was 3.1 years, and the num-
ber of male patients was 261 (60.6%). The incidence of 
hypoalbuminemia was 55.0% (237/431).
2) Clinical characteristics by serum albumin level 
Patients were divided into the normoalbuminemia (n 
= 194) and the hypoalbuminemia (n = 237) group on the 
basis of serum albumin level (Table 3). No statistically 
Table 3. Characteristics in normoalbuminemia and hypoalbuminemia group
Variable Albumin <3.5 g/dl (n = 237) Albumin ≥3.5 g/dl (n = 194) P-value
Clinical characteristic
Age (yr)   4.0 (1.6–8.8)   2.0 (0.9–6.7) NS
Male sex 141 (59.49) 120 (61.86) NS
Nutritional state NS
Well nourished 151 (63.71) 124 (63.92)
Malnourished  83 (35.02)  66 (34.02)
Obese (weight for age ≥97%)  3 (1.27)  4 (2.06)
Main reason for ICU admission
Airway-lung problem 151 (63.71) 117 (60.31) NS
Neurologic problem  24 (10.13)  40 (20.62) NS
Postoperation and procedure care 22 (9.28) 15 (7.73) NS
Hemato-oncologic emergency 10 (4.22)  5 (2.58) NS
Nephrologic problem  9 (3.80)  5 (2.58) NS
Gastrointestinal problem  8 (3.38)  1 (0.52) NS
Metabolic disease  1 (0.42)  2 (1.03) NS
Othersa 12 (5.06)  9 (4.64) NS
Laboratory variable
White blood cell (/µL) 9,190 (5,580–15,960) 12,640 (7,685–18,603) NS
Absolute neutrophil count (/µL) 6,700 (3,303–11,763)  8,922 (4,803–14,223) NS
Delta neutrophil index (%)  2.0 (0.0–7.1)   0.6 (0.0–3.6) <0.001
Hemoglobin (g/dl)  10.2 (8.8–11.4)   11.0 (9.8–12.1) <0.001
Platelets (103/µl)  206 (96–335)    341 (232–475) <0.001
Erythrocyte sedimentation rate (mm/h)  23.0 (7.0–64.5)    19.5 (4.75–48.0) NS
C-reactive protein (mg/L)  33.0 (8.5–97.5)   5.8 (0.9–24.2) <0.001
Lactate (mmol/L)  1.6 (0.9–3.1)  1.2 (0.7–1.9) <0.001
Length of ICU stay (d)  10.0 (4.0–19.0)   7.0 (4.0–17.0) NS
ICU scoring system
PIM 3 9.23 (4.52–29.48)  8.36 (3.80–18.80) <0.001
PRISM III   7.0 (3.0–13.0)  5.0 (0–10.0) <0.001
Mortality 64 (27.00) 20 (10.31) <0.001
28-Day mortality 59 (24.60) 18 (9.28) <0.001
Sepsis 53 (22.36)  29 (14.95) NS
Septic shock 28 (11.81)  5 (2.58) <0.001
Values are presented as median (interquartile range) or number (%).
NS: non-specific; ICU: intensive care unit; PIM: Pediatric Index of Mortality; PRISM: Pediatric Risk of Mortality.
aEndocrinologic emergency, close monitoring, cardiovascular disease.
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significant difference was observed in the age, sex, the 
nutritional status, the length of ICU stay, and the main 
reason for ICU admission between two groups.
The patients with hypoalbuminemia had higher delta 
neutrophil index (2.0% vs. 0.6%, P < 0.001), C-reactive 
protein (33.0 mg/L vs. 5.8 mg/L, P < 0.001), lactate level 
(1.6 mmol/L vs. 1.2 mmol/L, P < 0.001), PIM 3 (9.23 vs. 
8.36, P < 0.001), PRISM III (7.0 vs. 5.0, P < 0.001), 28-
day mortality rate (24.60% vs. 9.28%, P < 0.001), inci-
dence of septic shock (11.8% vs. 2.6%, P < 0.001), and 
lower hemoglobin level (10.2 g/dl vs. 11.0 g/dl, P < 0.001) 
and platelet level (206,000/μl vs. 341,000/μl, P < 0.001) 
compared to the normoalbuminemia group (Table 3). 
3)  Clinical characteristics in infection and non-infection 
group by serum albumin level
Patients were divided into infection group (n = 299) and 
non-infection group (n = 132) as we defined in the Mate-
rials and Methods. No statistically significant difference 
was observed in the age, sex, the nutritional status, and 
the length of ICU stay in both infection and non-infection 
group (Supplementary Tables 1 and 2). The patients with 
hypoalbuminemia had higher delta neutrophil index, C-
reactive protein, lactate level, PIM 3, PRISM III, 28-day 
mortality rate, incidence of septic shock, and lower he-
moglobin level and platelet level compared to the normo-
albuminemia patients in both infection and non-infection 
group (Supplementary Tables 1 and 2). This is consistent 
with the result of comparison of clinical characteristics in 
the total group by serum albumin level (Table 3).
4)  Clinical characteristics in infant and the other group 
by serum albumin level
Patients were divided by the age, infant group (n = 96) 
and the other group (age, ≥1 year; n = 335). No statistical-
ly significant difference was observed in the age, sex, the 
nutritional status, and the length of ICU stay in both age 
group (Supplementary Tables 3 and 4). The patients with 
hypoalbuminemia had higher delta neutrophil index, C-
reactive protein, lactate level, PIM 3, PRISM III, 28-day 
mortality rate, incidence of septic shock, and lower plate-
let level compared to the normoalbuminemia patients in 
both age groups as others (Supplementary Tables 3 and 4). 
Hemoglobin level was statistically significant in patients 
who were above 1 year old, but not for infant group. 
5) Serial serum albumin levels for the first 4 days in ICU
We compared serial serum albumin levels for the first 4 
days in ICU between survivors and non-survivors in hy-
poalbuminemia and normoalbuminemia group separately 
(Figure 1). Serum albumin level in survivors remained 
higher than non-survivors in both groups. Serum albumin 
level of non-survivors was below 3.5 g/dl in the second, 
third, and fourth day in ICU in both groups.
Figure 1. Albumin level in the first 4 days in intensive care unit in (A) normoalbuminemia group and (B) in hypoalbuminemia group. The 
box and plots represent mean and standard deviation. 
A B
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6) Albumin as a predictor of mortality in PICU patients
Serum albumin level in the survival group is higher 
than that in the non-survival group (3.4 g/dl [interquartile 
range, 3 to 3.8 g/dl] vs. 2.9 g/dl [interquartile range, 2.3 to 
3.4 g/dl], P < 0.001) (Figure 2). Figure 3 shows survival 
curves according to albumin level and it shows that the 
normoalbuminemia group has higher survival probability 
than the hypoalbuminemia group. In the univariable anal-
yses, nine variables including albumin were correlated 
with the mortality (P < 0.001) (Table 4). 
We also considered the relationship between serum al-
bumin at admission and pre-existing mortality prediction 
models used in ICU. Even though the correlation coeffi-
cients were low, each model was significantly correlated 
with serum albumin (Supplementary Table 5). The AUC 
was 0.702 for serum albumin, 0.802 for PIM 3, and 0.850 
for PRISM III score (Figure 4, Supplementary Table 5). 
There was no improvement of predicting mortality in 
the corporation of serum albumin to pre-existing mortal-
ity prediction models; however, incorporating albumin 
to pre-existing mortality prediction models showed a 
tendency to be more predictive of mortality than PIM 
3, PRISM III alone (Supplementary Table 6). The PIM 
3 with serum albumin provided an NRI of 21.0% (P = 
 Table 4. Univariable logistic regression for independent factor in mortality prediction
Variable Odds ratio 95% Confidence interval P-value
Age 1.058 1.004–1.114 0.034
Sex 0.932 0.560–1.551 0.787
Pediatric Index of Mortality 3 1.031 1.023–1.038  <0.001
Pediatric Risk of Mortality III 1.185 1.139–1.232  <0.001
Albumin 0.34 0.233–0.496  <0.001
C-reactive protein 1.008 1.005–1.010  <0.001
Delta neutrophil index 1.079 1.054–1.105  <0.001
Lactate 1.245 1.167–1.328  <0.001




















Survival (n = 347)
Figure 2. Albumin level between non-survival and survival 
group. Serum albumin level in the survival group was higher 
than the non-survival group (3.4 g/dl [interquartile range, 3 to 3.8 
g/dl] vs. 2.9 g/dl [interquartile range, 2.3 to 3.4 g/dl], P < 0.001). 
The error bar represents the median and interquartile range for 
each group.
Figure 3. Survival probability according to albumin level. 
Kaplan-Meier survival estimate for patients according to serum 
albumin level (albumin <3.5 g/dl vs. albumin ≥3.5 g/dl). This 
survival curve showed that the hypoalbuminemia group had 
lower survival probability than the normoalbuminemia group. 
















Time after PICU admission (d)
Serum albumin <3.5 g/dl
Serum albumin ≥3.5 g/dl
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0.136) and IDI of 4.3% (P = 0.158), and the PRISM III 
with serum albumin yielded an NRI of 24.5% (P = 0.388) 
and IDI of 2.1% (P = 0.416) (Supplementary Table 7).
Discussion
We showed that serum albumin concentration at ICU 
admission was higher in survivors compared with non-
survivors in children. Patients with hypoalbuminemia 
at ICU admission had higher mortality rate. In addition, 
serum albumin concentration was negatively correlated 
with pre-existing mortality prediction models including 
PIM 3 and PRISM III. 
The prevalence of hypoalbuminemia in critically ill 
children is about 33%–57% from previous studies [10-
12]. Hypoalbuminemia has long been a predictor of poor 
outcome, such as mortality, morbidity, and prolonged 
ICU and hospital stay [5]. There are many studies that 
low serum albumin concentration reflects disease sever-
ity and prognosis in critically ill adult patients [13-16]. 
Regarding pediatric patients, studies on this issue were 
limited to only some specific circumstances, such as 
cardiac surgery children, pediatric renal transplant recipi-
ents, showing that hypoalbuminemia is a risk factor for 
cardiac surgery and graft failure [17,18]. Serum albumin 
concentration as a predictor of clinical outcomes of criti-
cally ill children in general circumstances is so far incon-
clusive [10,11]. 
Albumin plays important role as an osmotic pres-
sure determinant balancing between intravascular and 
interstitial space, a non-specific carrier protein, and an 
antioxidant by scavenging of oxygen free radicals to 
protect against oxidant injuries [19,20]. The important 
determinants of serum albumin concentration in critically 
ill patients are synthetic rate and leakage of albumin to 
interstitial space from intravascular space [19,21]. As 
the clinical course of critically ill patients progresses, the 
distribution of albumin from intravascular to interstitial 
spaces occurs resulting from increases of capillary leak-
age by the response of systemic inflammation [20]. Since 
the leakage of albumin into the extravascular spaces is 
related to the degree of systemic inflammation [22], the 
development of hypoalbuminemia is liable to be seen 
in patients with poor clinical status. Owing to potency 
of albumin as an antioxidant agent, in addition to this 
kinetic and dynamic alteration of albumin in critically ill 
patients, hypoalbuminemia is associated with poor clini-
cal outcomes such as mortality, morbidity and prolonged 
hospital stay in critically ill patients [5,23].
Mortality is the worst outcome of clinical management 
in ICU setting. Early recognition of probability of mor-
tality in critically ill patients can help to make prompt 
and precise decision to give the best treatment to patients 
by risk stratification. Therefore, predicting mortality risk 
is a major concern of ICU care. Several predictive indi-
ces have been suggested to predict the risk of death in 
critically ill children of ICU, but some predictive indices 
are too complicated demanding too much information to 
calculate the mortality risk. As a result, there has been 
Figure 4. Receiver operating characteristic curves for mortal-
ity between albumin and intensive care unit mortality scoring 
systems. Area under the receiver operating characteristic curve: 
PRISM III, 0.850 (95% CI, 0.801 to 0.899); PIM 3, 0.802 (95% CI, 
0.747 to 0.858); albumin, 0.702 (95% CI, 0.633 to 0.772). PRISM: 
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an increasing need to establish a clinical value to use in 
children in ICU easily. Several biomarkers such as delta 
neutrophil index, C-reactive protein, and thrombocyto-
penia have been suggested as predictors of poor progno-
sis including mortality in children in ICU [24-26].
We designed this study to investigate whether hypoal-
buminemia at admission can predict prognosis including 
mortality in pediatric patients in ICU. Comparing hypo-
albuminemia group of patients and normoalbuminemia 
group of patients, we showed that hypoalbuminemia at 
admission to ICU was associated with the higher mortal-
ity, regardless of the underlying disease. Furthermore, 
even though there was no statistical significance, incor-
poration of serum albumin at admission to other predic-
tive indices showed a tendency to be more predictive in 
this study. This shows that serum albumin concentration, 
which could be obtained through a simple, sensitive, low 
cost assay, could help assessing the current status and 
predicting outcomes of critically ill pediatric patients in 
ICU. 
There are some limitations in the current study. First, 
this study was limited to the single center using the data 
collected retrospectively. Since serum albumin level be-
low 2.5 g/dl were replaced and above 2.5 g/dl were not in 
this retrospective data, this study was not able to evalu-
ate the effectiveness of albumin replacement. Therefore, 
further studies might be needed in a multicenter setting 
using prospective data.
In conclusion, hypoalbuminemia at admission was as-
sociated with higher mortality in children in ICU. We 
suggest that hypoalbuminemia at admission could be 
used as a biomarker of poor prognosis of children in 
ICU, regardless of underlying etiology.
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